Recursion Pharmaceuticals, Inc. (RXRX) NASDAQ

4.09

-0.02(-0.49%)

Updated at December 31 04:00PM

Currency In USD

Valuation

Market Cap1.85B
Enterprise Value1.37B
P/E Ratio-2.63
PEG Ratio4.66
Price/Sales Ratio25.44
Price/Book Ratio1.86
Enterprise/Revenue18.61
Enterprise/EBITDA-2.06

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin-10.07
Operating Margin-10.08

Management Effectiveness

Return On Assets-0.5
Return On Equity-0.76

Income Statement

Revenue58.84M
Revenue/Share0.15
Gross Profit13.6M
EBITDA-426.72M
Net Income-463.66M
Diluted EPS-1.69

Balance Sheet

Total Cash659.84M
Total Cash/Share1.27
Total Debt82.37M
Total Debt/Equity0.1
Current Ratio3.58
Book Value Per Share2.2

Price History

52-Week Change-39.5
52-Week High12.36
52-Week Low3.79
Moving Average 50 Days4.77
Moving Average 200 Days5.12

Statistics

Average Volume41.79M
Shares Outstanding400.82M
% Held by Institutions77.82

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A